STOCK TITAN

RxSight (RXST) director Corley Jesse Anderson granted 37,037 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Corley Jesse Anderson reported acquisition or exercise transactions in this Form 4 filing.

RxSight, Inc. director Corley Jesse Anderson received a grant of 37,037 restricted stock units (RSUs) of Common Stock as compensation. Each RSU represents one share and was granted at $0.00 per share. Subject to his continuing service as an Outside Director, all RSUs vest on the earlier of the one-year anniversary of the June 17, 2026 grant date or the next annual stockholder meeting. Following the grant, he holds 86,227 shares directly and additional indirect positions through the Andy Corley Living Trust, The Corley Foundation, the Juana McKay Living Trust, and shares held by his spouse.

Positive

  • None.

Negative

  • None.
Insider Corley Jesse Anderson
Role null
Type Security Shares Price Value
Grant/Award Common Stock 37,037 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 86,227 shares (Direct, null); Common Stock — 3,210 shares (Indirect, By spouse)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee. Shares held by The Corley Foundation (the "Foundation"). The Foundation is a California nonprofit public benefit corporation. The Reporting Person may be deemed to share voting and investment power over the securities held by the Foundation. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Shares held by the Juana McKay Living Trust, for which the Reporting Person's spouse serves as trustee.
RSU grant size 37,037 RSUs Granted June 17, 2026 as equity award
Grant price per share $0.00 per share RSU grant to Outside Director
Direct holdings after grant 86,227 shares Common Stock directly owned after RSU grant
Andy Corley Living Trust holdings 18,708 shares Indirect ownership via trust where Anderson is trustee
The Corley Foundation holdings 7,083 shares Indirect; Anderson may share voting and investment power
Juana McKay Living Trust holdings 474,141 shares Indirect via spouse as trustee
Spouse-held shares 3,210 shares Indirect ownership by spouse
Vesting condition 100% cliff vesting Earlier of 1-year from June 17, 2026 or next annual meeting
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Outside Director financial
"Subject to the Reporting Person's continuing as an Outside Director through such applicable vesting date"
2021 Equity Incentive Plan financial
"as defined in the Issuer's 2021 Equity Incentive Plan"
pecuniary interests financial
"disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein"
nonprofit public benefit corporation other
"The Corley Foundation is a California nonprofit public benefit corporation"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Corley Jesse Anderson

(Last)(First)(Middle)
C/O RXSIGHT, INC.
100 COLUMBIA

(Street)
ALISO VIEJO CALIFORNIA 92656

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)06/17/2026A37,037(2)A(1)86,227D
Common Stock3,210IBy spouse
Common Stock474,141ISee footnote(3)
Common Stock7,083ISee footnote(4)
Common Stock18,708ISee footnote(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
2. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.
3. Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee.
4. Shares held by The Corley Foundation (the "Foundation"). The Foundation is a California nonprofit public benefit corporation. The Reporting Person may be deemed to share voting and investment power over the securities held by the Foundation. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
5. Shares held by the Juana McKay Living Trust, for which the Reporting Person's spouse serves as trustee.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Jim Schindler, as Attorney-in-Fact06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity award did Corley Jesse Anderson report at RxSight (RXST)?

Corley Jesse Anderson reported receiving a grant of 37,037 restricted stock units (RSUs) of RxSight Common Stock at $0.00 per share. Each RSU represents one share, reflecting a stock-based compensation award rather than an open-market purchase.

How do the new RxSight (RXST) RSUs granted to Anderson vest?

All RSUs vest in a single tranche, subject to Anderson continuing as an Outside Director. Vesting occurs on the earlier of the one-year anniversary of the June 17, 2026 grant date or the date of the next annual meeting of stockholders following that grant date.

How many RxSight (RXST) shares does Anderson hold directly after this Form 4?

After the RSU grant, Anderson is shown holding 86,227 shares of RxSight Common Stock directly. This reflects his direct ownership position reported in the filing and does not include additional shares held indirectly through trusts or his spouse.

What indirect RxSight (RXST) holdings are associated with Anderson on this Form 4?

Indirect holdings include shares held by the Andy Corley Living Trust, The Corley Foundation, the Juana McKay Living Trust, and shares held by his spouse. The filing notes he may share voting and investment power over certain Foundation shares and disclaims full beneficial ownership.

Is Anderson’s RxSight (RXST) Form 4 transaction a market buy or sell?

The Form 4 reports a grant of RSUs, coded as an acquisition (A), not an open-market buy or sell. No transaction price above $0.00 is disclosed, indicating this is stock-based compensation rather than trading activity in the public market.

What does each RxSight (RXST) RSU reported by Anderson represent?

Each restricted stock unit reported represents a contingent right to receive one share of RxSight Common Stock. Delivery of the underlying shares depends on satisfaction of the vesting conditions tied to Anderson’s continued service as an Outside Director through the specified vesting date.